Prognostic Factors of Peripheral Blood Stem Cell Mobilization with Cyclophosphamide and Filgrastim (r-metHuG-CSF): The CD34+Cell Dose Positively Affects the Time to Hematopoietic Recovery and Supportive Requirements after High-Dose Chemotherapy
Year: 1999
Type: article
Source: Hematology
Institutions: Universitat Autònoma de Barcelona, Hospital de Sant Pau
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Amgen
OpenAlex ID: W2472385896
